ADAD — Huaizhong Health Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual income statement for Huaizhong Health, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.021 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.005 | 0 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.027 | 0.126 | 0.036 | 0.031 | 0.029 |
| Operating Profit | -0.006 | -0.126 | -0.036 | -0.031 | -0.029 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.006 | -0.126 | -0.036 | -0.031 | -0.029 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.006 | -0.126 | -0.036 | -0.031 | -0.029 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.006 | -0.126 | -0.036 | -0.031 | -0.029 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.006 | -0.126 | -0.036 | -0.031 | -0.029 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.002 | -0.408 | -0.003 | -0.001 | -0.001 |